Supply Chain

The Food and Drug Administration approved Sanofi's new drug Adlyxin to treat adults with type 2 diabetes.

GlaxoSmithKline purchased the global rights to an experimental asthma drug from Johnson & Johnson for $230 million, according to Reuters.

Texas hospitals are feeling the effects of the national blood shortage.

Merck reported an unexpected revenue increase in the second quarter due to the success of its cancer drug Keytruda and new hepatitis treatments.

AspireBariatrics'stomach-pumping weight loss device AspireAssist, which was approved by the Food and Drug Administration in June, has been making waves in the medical device community.

Unbundle your purchasing program from top-line rebates that hurt your bottom line

Mundelein, Ill.-based Medline recently agreed to a five year, $112 million prime vendor deal with UMass Memorial Health Care in Worcester, Mass.

John Lechleiter, PhD, will step down from his role as president and CEO of Indianapolis-based Eli Lilly by the end of the year, according to Reuters.

Chris Johnson has served as head of supply chain at Tufts Medical Center in Boston since 2015.

Easton (Pa.) Hospital has upgraded its radiation therapy technology with a new linear accelerator, the organization announced Tuesday.